Microbicide offers no protection against HIV infectionBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b5538 (Published 18 December 2009) Cite this as: BMJ 2009;339:b5538
- Bob Roehr
- 1Washington DC
There has been another setback in efforts to develop a microbicide to protect women against HIV infection during vaginal sex. Results of a large clinical trial of PRO 2000, released on 14 December, showed that although the product was safe, it was not effective against infection.
The large (9385 women) double blind, placebo controlled trial (called MDP 301) was conducted by the Microbicides Development Programme—a broad international collaboration—in South Africa, Tanzania, Uganda, and Zambia. It had substantial support …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial